Back to catalogue
№ 041 27 filings · 2021-09-10 → 2026-09-25

ASHMORE GROUP PLC

ASHM
Financial Services Share price 225p Market cap £1.5bn Overall fit 400 /1000

Fair valuation, high operating leverage and fortress balance sheet are attractive, but Ashmore has essentially no direct AI-receiver exposure and remains a cyclical EM asset manager whose adjusted EPS has fallen 78% over five years. Fits the 'partial fit — worth knowing about' band.

Fair value range 200p–240p Mid case · £1.4bn
Absolute upside -2.4% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Clean, well-disclosed financials with detailed adjusted vs reported reconciliations
  • Fortress balance sheet (£609m capital resources, no debt) anchors downside
  • Multiple valuation approaches (SOTP, % of AuM) converge on similar range
Limits the call
  • Wide range of plausible AuM recovery outcomes drives EPS uncertainty (4-10p adjusted)
  • Seed capital mark-to-market makes statutory earnings noisy and headline P/E misleading
Methodology

SOTP: excess regulatory capital plus normalised earnings multiple, cross-checked vs % of AuM

In one line · bull case

Post-cycle inflection in EM flows, high operating leverage and a fortress balance sheet offer recovery upside, but at a broadly fair price and with essentially no direct AI-receiver exposure.

In one line · biggest risk

A stalled or reversed EM recovery leaves adjusted EPS stuck near 5p, exposing the current valuation as too optimistic and the dividend under pressure.

Drivers
AI beneficiary 20 /100
Only indirect exposure via EM equity funds benefiting from AI capex flowing to Korean/Taiwanese semis; Ashmore itself captures no AI spend.
Operating leverage 72 /100
Fixed non-VC costs of ~£58m against £128m net management fees; platform previously ran US$94bn AuM so significant spare capacity for incremental revenue to drop to profit.
Earnings vs expectations 40 /100
Adjusted diluted EPS declined every year FY21-FY26 (23.3p to 5.0p); FY26 reported EPS beat is a seed capital artefact rather than operating outperformance.
Growth momentum 55 /100
FY26 marked an inflection — first net inflow year since 2020 (US$2.7bn) and 13% AuM growth — but from a low base and one year of recovery does not yet confirm a durable trend.
Moat 45 /100
Specialist EM franchise with 30+ year track record and local office network provides some defensibility, but faces passive competition and structural EM allocation headwinds.
Earnings quality 50 /100
Statutory earnings heavily distorted by unrealised seed-capital mark-to-market (£82.5m gain in FY26, £49.9m loss in FY22); underlying operating earnings are much lower and more volatile.
Management quality 55 /100
Founder-CEO Mark Coombs has run a consistent strategy for 30+ years and maintains an appropriate cost/capital discipline, but AuM has halved over the five-year period covered.
Cyclicality 65 /100
EM asset management is inherently cyclical with AuM and flows highly sensitive to global risk appetite and US dollar cycles.
Leverage 5 /100
£355m net cash, no debt, £521m excess regulatory capital — one of the most conservative balance sheets in the sector.
Value-trap signals · 5
  • AuM halved from US$94bn (FY21) to US$47.6bn (FY25) before FY26 inflection
  • Adjusted diluted EPS declined 78% over five years from 23.3p to 5.0p
  • Persistent net outflows every year FY21-FY25 before FY26 turnaround
  • Dividend cover only 0.9x in FY26 (0.7x in FY25) — dividends partly funded from capital
  • Founder-CEO controls voting stake, limiting corporate action optionality

ASHMORE GROUP PLC (ASHM) — Investment Research Note

Executive summary

Ashmore is a specialist Emerging Markets asset manager (fixed income, equities, alternatives) with US$54.0bn of AuM, running a scalable, capital-light platform with c.£600m of capital resources and no debt. Across the five-year window, AuM has approximately halved from a peak of US$94.4bn (FY21) to US$47.6bn (FY25) driven by persistent institutional de-risking from EM, before inflecting positively in FY26 with the first net inflows (+US$2.7bn) since 2020 and 13% AuM growth. The single most important point for valuation today is that FY26's reported 28% EPS growth is a seed-capital mark-to-market artefact — adjusted diluted EPS actually fell 29% to 5.0p, and the current 214.6p price implies the market is already discounting a normalisation of adjusted EPS towards 7–10p as flows recover.

Fair value estimate

Methodology: Sum-of-parts (excess capital + normalised earnings multiple), cross-checked against a % of AuM valuation.

  • Excess capital: £521.5m of surplus regulatory capital (86p/share) plus £47m of tangible investment carrying value in seed funds not required for regulation = c.90–95p/share tangible backing.
  • Operating business: On a normalised adjusted diluted EPS of 7–9p (mid-cycle assumption, between the 5.0p FY26 trough and 10.5p FY24 mid-point, reflecting some AuM recovery), applying a 14–17x P/E (specialist EM peer range, discount for cyclicality) = 105–150p.
  • Sum: 195–245p per share, midpoint c.220p.
  • Cross-check: At mid-cycle AuM of US$60bn and 2.0–2.5% of AuM (typical for specialist EM), operating value = £900–1,100m + £520m excess capital = £1,420–1,620m, or 220–250p per share.

Fair value range: 200p – 240p per share, or £1,300m – £1,560m market cap. Latest disclosed market cap £1,396.6m sits mid-range. Upside vs current 214.6p: approx. –7% to +12%; midpoint c.+2%. Stock looks broadly fairly valued.

Sector context

Confirmed Financial Services (asset management sub-industry). Ashmore's profile relative to typical asset-management peers: quality — above average (fortress balance sheet, no debt, ~40% underlying adjusted EBITDA margin excluding seed VC); growth — below average (structural AuM decline over 5 years, only just inflecting); leverage — well below average (net cash of c.£355m). Listed EM-specialist peers: Man Group (broader hedge fund), Abrdn (broader UK asset manager with EM exposure), Franklin Resources (US-listed, larger scale). Ashmore stands out for its "pure play" EM focus.

Investment thesis (3 bullets)

  • Inflection in flows and AuM after a brutal cycle. FY26 delivered US$2.7bn of net inflows vs US$5.8bn of outflows in FY25, and AuM rose 13% to US$54bn with subscriptions +92% YoY. Management commentary and Q1 FY27 quarterly updates indicate continued momentum, particularly in equities and Latin America 2026-09 final results, 2026-07 trading update.
  • Operating leverage on any AuM recovery is substantial. Non-VC fixed costs are only £58m against £128m of net management fees; the platform managed US$94bn at peak and could absorb doubling of AuM with minimal cost growth. Excluding seed-capital VC, adjusted EBITDA margin was 40% in FY26 (up from 37%) 2026-09 final results.
  • Downside protected by a fortress balance sheet and dividend. £609m of capital resources including £355m cash, no debt, 16.9p dividend maintained for the sixth consecutive year giving a 7.9% yield at 214.6p, and £47m of unrealised life-to-date gains embedded in seed capital 2026-09 final results.

Key risks (3 bullets)

  • Adjusted earnings quality is weak — reported EPS is heavily inflated by unrealised seed-capital gains. FY26 statutory PBT of £126.9m includes £82.5m of seed capital gains; adjusted (ex-seed, ex-FX) PBT was only £43.7m, down 38% YoY. A reversal in seed marks (as in FY22 when they lost £49.9m) would sharply reduce headline EPS 2026-09 final results.
  • Structural pressure on fee margins. Net management fee margin has drifted from 39bps (FY24) to 35bps (FY25) to 34bps (FY26), reflecting theme mix (more overlay AuM, lower-margin) and competition. This offsets a substantial portion of AuM growth benefits 2026-09 final results.
  • EM allocation cycle remains investor-dependent. US investors are still <10% of Ashmore's AuM vs historical >20%. The "great rotation" from US assets to EM has not yet delivered institutional flows at scale, and geopolitical shocks (Middle East, Ukraine) or a stronger US dollar could delay the recovery further 2026-09 final results, 2026-04 Q3 trading update.

Operating leverage

Ashmore has a high operating leverage structure typical of a scaled asset manager. Fixed base costs (salaries £32.3m, other operating £22.3m, D&A £3.6m = £58m in FY26) plus a variable compensation charge accrued at 30% of pre-VC profit. With FY26 net management fees of £128m at a 34bps margin, each additional US$10bn of AuM (at current mix) would generate c.£25m of incremental revenue at c.70% incremental margin after VC, so c.£18m PBT — meaningful relative to FY26 adjusted PBT of £43.7m. A 10–20% revenue beat above current expectations would plausibly add 50–100% to adjusted operating profit given the peak-to-trough halving of AuM has left significant spare operating capacity (the platform managed US$94bn as recently as FY21). Excluding the £18.5m of seed-related VC, the underlying adjusted EBITDA margin was 40% in FY26 versus 37% in FY25, illustrating margin expansion even at trough AuM 2026-09 final results.

Value-trap signals

  • Multi-year AuM decline from US$94bn (FY21) to US$47.6bn (FY25) — 50% peak-to-trough — reflecting structural repositioning away from EM by developed-world institutions.
  • Adjusted diluted EPS trend deeply negative: 23.3p (FY21) → 18.7p (FY22) → 12.7p (FY23) → 10.5p (FY24) → 7.1p (FY25) → 5.0p (FY26). A 78% cumulative decline over 5 years.
  • Persistent net outflows every year FY21–FY25, with FY26 the first inflow year. The recovery is nascent.
  • Dividend cover only 0.9x in FY26 (up from 0.7x in FY25), indicating dividends have been funded partly out of capital.
  • CEO-founder Mark Coombs holds a controlling stake (Rule 9 whitewash referenced annually), which limits corporate action optionality. These factors mitigate but do not eliminate value-trap risk given the observed FY26 inflection.

Earnings vs expectations

The filings do not systematically disclose analyst consensus vs actuals, so this is partial. Across the five-year sequence: FY22 statutory EPS 13.4p (versus FY21 36.4p — sharp decline driven by seed losses reversing); FY23 12.4p; FY24 13.9p; FY25 12.2p; FY26 15.7p basic / 15.0p diluted. On an operating (adjusted diluted) basis, the trend has been steadily disappointing each year (18.7→12.7→10.5→7.1→5.0p) as AuM contracted, though FY26 reported EPS beat because of a large unrealised seed gain. Management has consistently guided cautiously ("AuM depends on markets and flows") rather than providing specific numeric targets, so the misses are relative to prior year rather than to formal guidance. Pattern: mostly misses on the operating trajectory, but the FY26 headline flatters this via non-cash seed items.

Conviction

Conviction: 3 — moderate.

Anchors (support confidence): (i) Very clean, well-disclosed accounting with detailed reconciliations of adjusted vs reported figures. (ii) Long history and consistent business model make the valuation methodology (SOTP on excess capital + normalised earnings multiple) unambiguous. (iii) Fortress balance sheet and predictable regulatory capital requirement anchor the downside.

Caveats (limit confidence): (i) The pace of AuM recovery and future net management fee margin are genuinely uncertain — a plausible bull case (US$70bn AuM in 3 years) would deliver ~9–10p adjusted EPS and support 250–300p; an equally plausible bear case (renewed EM risk-off, AuM back to US$45bn) would keep adjusted EPS near 4–5p and cap fair value at 160–180p. (ii) Statutory earnings are noisy due to seed capital mark-to-market, making headline P/E comparisons unreliable.

Driver scoring rationale (summary)

Ashmore is a low AI beneficiary (EM equity funds benefit indirectly from AI capex in Korean/Taiwanese semis, but Ashmore itself captures no AI spend); high operating leverage (fixed cost base ~£60m against £128m net management fees with substantial spare capacity from prior peak AuM); moderate cyclicality (EM asset management is cyclical); narrow-to-moderate moat (specialist franchise but facing passive competition and structural EM allocation headwinds); fortress balance sheet; moderate earnings quality (heavy seed-capital MTM distortion); moderate management quality (consistent strategy, founder-led, but AuM has halved over five years); improving growth momentum post FY26 inflection.

Overall fit for the target investor: moderate-to-low. The AI angle is very weak (score dragged down by the 35% weighting on AI-receiver alignment). Valuation looks fair, not cheap, and while operating leverage and downside protection are attractive, this is fundamentally an EM asset manager, not an AI-cycle beneficiary.

Filings consulted · 42

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-25Notice OF Agm2026-09-25_9792119_notice-of-agm.md0.30
  2. 2026-09-07Final Results2026-09-07_9757562_final-results.md1.00
  3. 2026-07-14Trading Statement2026-07-14_9666632_trading-statement.md0.85
  4. 2026-04-16Trading Statement2026-04-16_9522474_trading-statement.md0.85
  5. 2026-02-12Half Year Financial Report2026-02-12_9426793_half-year-financial-report.md0.77
  6. 2026-01-15Trading Statement2026-01-15_9354391_trading-statement.md0.72
  7. 2025-11-06Result OF Agm2025-11-06_9217560_result-of-agm.md0.26
  8. 2025-10-14Trading Statement2025-10-14_9168673_trading-statement.md0.72
  9. 2025-09-25Notice OF Agm2025-09-25_9132095_notice-of-agm.md0.20
  10. 2025-09-05Final Results2025-09-05_9090119_final-results.md0.65
  11. 2025-07-14Trading Statement2025-07-14_8976560_trading-statement.md0.55
  12. 2025-04-14Trading Statement2025-04-14_8828245_trading-statement.md0.55
  13. 2025-02-07Half Year Report2025-02-07_8726251_half-year-report.md0.58
  14. 2025-01-15Trading Statement2025-01-15_8688688_trading-statement.md0.55
  15. 2024-11-06Result OF Agm2024-11-06_8534034_result-of-agm.md0.20
  16. 2024-10-14Trading Statement2024-10-14_8483156_trading-statement.md0.55
  17. 2024-09-25Notice OF Agm2024-09-25_8438515_notice-of-agm.md0.14
  18. 2024-09-05Final Results2024-09-05_8400462_final-results.md0.45
  19. 2024-07-12Trading Statement2024-07-12_8307734_trading-statement.md0.38
  20. 2024-04-15Trading Statement2024-04-15_8136325_trading-statement.md0.38
  21. 2024-02-07Half Year Report2024-02-07_8025276_half-year-report.md0.41
  22. 2024-01-15Trading Statement2024-01-15_7988425_trading-statement.md0.38
  23. 2023-10-18Result OF Agm2023-10-18_7824809_result-of-agm.md0.14
  24. 2023-10-13Trading Statement2023-10-13_7814047_trading-statement.md0.38
  25. 2023-09-14Notice OF Agm2023-09-14_7756309_notice-of-agm.md0.07
  26. 2023-09-06Final Results2023-09-06_7737647_final-results.md0.25
  27. 2023-07-14Trading Statement2023-07-14_7632125_trading-statement.md0.21
  28. 2023-04-17Trading Statement2023-04-17_7491714_trading-statement.md0.21
  29. 2023-04-14Agm Statement2023-04-14_7490819_agm-statement.md0.10
  30. 2023-02-08Half Year Report2023-02-08_7402056_half-year-report.md0.23
  31. 2023-01-16Trading Statement2023-01-16_7435826_trading-statement.md0.21
  32. 2022-10-14Trading Statement2022-10-14_7347364_trading-statement.md0.21
  33. 2022-10-14Result OF Agm2022-10-14_7348889_result-of-agm.md0.07
  34. 2022-09-09Notice OF Agm2022-09-09_7273597_notice-of-agm.md0.07
  35. 2022-09-02Final Results2022-09-02_7165767_final-results.md0.25
  36. 2022-07-14Trading Statement2022-07-14_6994888_trading-statement.md0.21
  37. 2022-04-14Trading Statement2022-04-14_6945938_trading-statement.md0.21
  38. 2022-02-10Half Year Report2022-02-10_6800392_half-year-report.md0.23
  39. 2022-01-17Trading Statement2022-01-17_6856603_trading-statement.md0.21
  40. 2021-10-15Result OF Agm2021-10-15_6814638_result-of-agm.md0.07
  41. 2021-10-14Trading Statement2021-10-14_6811334_trading-statement.md0.21
  42. 2021-09-10Notice OF Agm2021-09-10_6823317_notice-of-agm.md0.03

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-09-10 and 2026-09-25. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.